One hundred ECMO retrivals before and during the Covid-19 pandemic: an observational study

VV‐ECMO as bridge and safety net for successful therapeutic polypragmasy in a case of influenza‐triggered near‐fatal asthma

“…The on-site ECMO implantation and transport under ECMO are generally considered safe to perform, an experience that has also been consolidated during the COVID pandemic. 11,12 Although the use of ECMO in the described case can be considered free of major complications, minor bleeding from the cannulation sites required repetitive transfusion of blood products (in total 14 red blood cells and 2 platelet concentrates). Due to the necessity of anticoagulation, bleeding is among the most common complications in ECMO therapy.…”

“…Transport to an ECMO center requires on‐site ECMO cannulation and initiation in some clinical situations to allow for transport. The on‐site ECMO implantation and transport under ECMO are generally considered safe to perform, an experience that has also been consolidated during the COVID pandemic 11,12 …”

Qualitative study of COVID-19 patient experiences with non-invasive ventilation and pronation: strategies to enhance treatment adherence

“…Similar perceptions of discomfort emerged in a recent study of covid-9 patients with helmet-CPAP treatment postextubation. 22 From these experience reports, we may define some healthcare interventions to improve patient's adherence through comfort actions, such as paying attention to comfort: helping the patient to find the right position, applying a hair cap, earplugs or earbuds and glasses (to let patients listen to their favourite music or read something). These practical measures allow patients to better overcome the discomfort caused by noise and the time of treatments.…”

“…10 25 The strategies adopted by participants that have emerged in other studies also correspond to those found in our study and may suggest some healthcare interventions in the relationship with patients that could improve treatment adherence. 22 Giving news about clinical conditions in an encouraging way and making improving parameters visible on monitor, report clear feedback on the evolution and benefits of the treatments and how it Open access is going. Moreover, providing support to patients with information and explanations on the physiological needs and tangible benefits related to the treatments, before starting to use the device, can establish a relationship of trust with the patient and alleviate fears.…”

“…The latter aspect is also emphasised in other previous studies. 22 25 In terms of limitations, all participants were recruited from a single centre and were Italian speaking, suggesting some sociodemographic homogeneity. The time between discharge and interview may represent a selection bias, it would be important to include patients who have just been discharged.…”